Eli Lilly's triple-agonist shot retatrutide hit 22.6% weight loss in two more Phase 3 trials — its fifth straight win, with an FDA filing due Q1 2027.
Skyroot's Vikram-1 just became the first privately built Indian rocket to reach orbit, making India the third nation with a private launch capability — and its builder is a $1.1B unicorn.
Etched just raised $300M at a $10.3 billion valuation — more than doubling in seven months on a chip that deliberately runs only transformers. Inside the boldest bet against the GPU.
Valar Atomics tripled to a $6B valuation in four months, with Sequoia set to lead a $1B round — after a 27-year-old dropout's reactor powered a live Nvidia AI chip.
In June 2026, 90,000 AI-generated tracks hit Deezer every day — over half of all new uploads. But they're just 1-3% of streams, and 85% of their plays are fraudulent.
Travis Kalanick's new company Atoms just raised $1.7 billion in an a16z-led round for industrial AI — and Uber, the company that fired him in 2017, is one of the backers.
AMD's new Helios rack packs 72 GPUs and 31TB of memory — 50% more than Nvidia's Vera Rubin — plus a 256-core 2nm CPU, with OpenAI, Meta and Oracle already on board.
Munich's Helsing just raised $1.8 billion at an $18 billion valuation — Europe's biggest defense-tech round ever, chaired by Spotify's Daniel Ek.
London's Humanoid raised a $152M Series A at a $1.35B valuation to become Europe's first pure-play humanoid robot unicorn — two years old, and not a single robot shipped.
CuspAI just raised a $450M Series B at a $2.6B valuation — 5x its worth nine months ago — to use AI to invent the materials the physical world is missing. Kleiner Perkins and NEA led; Bezos Expeditions backed.
Merck's Lipfendra (enlicitide) is the first oral PCSK9 inhibitor — a once-daily pill that cuts LDL up to 59%, matching the injectables at $315 a month.
SAP just closed its €1B+ acquisition of Prior Labs, an 18-month-old Freiburg lab building tabular foundation models — AI for spreadsheets and databases, not chatbots.
